About Kendall Research Systems
Kendall Research Systems is a Healthcare company based in Cambridge (United States) founded in 2011, and was acquired by Kernel in February 2017. A wireless optogenetics platform for neuroscience drug discovery is developed. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Genomics. Its competitors include PacBio, Omniome and Complete Genomics; 3 of its 3 listed competitors have raised funding.
Company details
Kendall Research Systems was established in 2011 as a spin-out from MITs Synthetic Neurobiology Lab. A wireless optogenetics platform has been created for drug discovery applications, with emphasis on in vivo neuroscience research. Operations are conducted in the biotechnology sector from Cambridge, United States, supporting advancements in synthetic biology and neural studies.
- Headquarters Cambridge, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website kendallresearchsys.com
- Social LinkedIn Facebook
- Acquired by Kernel (Feb 2017)
Investors in Kendall Research Systems
Kendall Research Systems has secured backing from 1 investor. Prominent investors backing the company include Kernel.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Multimodal brain measurement technology is developed for neuromedicine applications. | 2016 | kernel.com | Los Angeles, United States |
Investor details for Kendall Research Systems
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Kendall Research Systems
2 dated milestones of Kendall Research Systems across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Kendall Research Systems is founded.
- Exit Acquired by Kernel.
Competitors of Kendall Research Systems
Kendall Research Systems has 3 listed competitors in our database, 3 of them funded. They include PacBio, Omniome and Complete Genomics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| pacb.com | 2004 | Menlo Park, United States | $395M | 649 | Instrument systems and software for single-molecule real-time sequencing are developed. | |
| omniome.com | 2013 | San Diego, United States | $160.23M | 164 | Genome sequencing platform is provided for clinical diagnostics. | |
| completegenomics.com | 2006 | San Jose, United States | $124.99M | 70 | DNA sequencing platform for human genome analysis is developed. |
Detailed competitors of Kendall Research Systems
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Kendall Research Systems (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Kendall Research Systems
Kendall Research Systems was founded in 2011.
Kendall Research Systems is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Kendall Research Systems was established in 2011 as a spin-out from MITs Synthetic Neurobiology Lab. A wireless optogenetics platform has been created for drug discovery applications, with emphasis on in vivo neuroscience research. Operations are conducted in the biotechnology sector from Cambridge, United States, supporting advancements in synthetic biology and neural studies.
Kendall Research Systems's top competitors include PacBio, Complete Genomics and Omniome.
Kendall Research Systems has 1 investor. Key investors include Kernel.
Yes. Kendall Research Systems was acquired by Kernel in February 2017.